An AI-driven multi-omics framework identifies lactylation-mediated therapeutic targets to overcome drug resistance in ovarian cancer

Abstract excerpt

Lactylation, a recently identified histone modification derived from lactate metabolism, has emerged as a critical regulator of epigenetic reprogramming, tumor proliferation, and immune evasion. In ovarian cancer, lactate dehydrogenase A (LDHA) and other metabolic enzymes contribute to lactate accumulation, which supports chemotherapy resistance and disease progression. Although lactylation is increasingly linked...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cancer, Hypoxia, and Metabolism
• Share to Ferroptosis and cancer prognosis
• Share to Immune cells in cancer